| Product NDC: | 52544-295 |
| Proprietary Name: | Amethyst |
| Non Proprietary Name: | Levonorgestrel and Ethinyl Estradiol |
| Active Ingredient(s): | 20; 90 ug/1; ug/1 & nbsp; Levonorgestrel and Ethinyl Estradiol |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52544-295 |
| Labeler Name: | Watson Pharma, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA079218 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110613 |
| Package NDC: | 52544-295-28 |
| Package Description: | 1 BLISTER PACK in 1 CARTON (52544-295-28) > 28 TABLET in 1 BLISTER PACK |
| NDC Code | 52544-295-28 |
| Proprietary Name | Amethyst |
| Package Description | 1 BLISTER PACK in 1 CARTON (52544-295-28) > 28 TABLET in 1 BLISTER PACK |
| Product NDC | 52544-295 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Levonorgestrel and Ethinyl Estradiol |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110613 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Pharma, Inc. |
| Substance Name | ETHINYL ESTRADIOL; LEVONORGESTREL |
| Strength Number | 20; 90 |
| Strength Unit | ug/1; ug/1 |
| Pharmaceutical Classes | Inhibit Ovum Fertilization [PE],Progesterone Congeners [Chemical/Ingredient],Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Progestin-containing Intrauterine Device [EPC],Estrogen [EPC],Estrogen Receptor Agonists [MoA] |